Zenalux Biomedical (Durham, NC) has licensed a proprietary spectral analysis algorithm from the Wisconsin Alumni Research Foundation (WARF; Madison, WI) to quantify visible light spectroscopy measurements in biological tissue. The University of Wisconsin developed the algorithm to provide accurate information about the composition of tissue, enabling a painless, nondestructive approach to measuring the underlying physiological, structural and biological nature of the tissue being investigated.
Zenalux is implementing the algorithm in its first product, Zenascope PC1, a specialized, real-time, diagnostic device that shines light on biological tissue and then measures and analyzes the remitted signal. The device uses the proprietary software algorithm and standard measurement hardware to achieve rapid, quantitative and non-destructive analysis of important biological endpoints that reflect the biological and physiological nature of the tissue specimen.
Planned for debut in the second quarter of 2011 , Zenascope PC1 can measure hemoglobin, hemoglobin saturation and scattering concurrently. The PC1 has an electronic records-keeping feature that will automatically record all measurements according to subject name and measurement location. Pre-clinical and clinical studies have demonstrated the efficacy of this quantitative diagnostic technique both in-vivo and ex-vivo in accelerating feedback in drug discovery, breast tumor margin assessment, breast biopsy, cervical cancer and head and neck cancer detection.
Posted by Lee Mather
Follow OptoIQ on your iPhone; download the free app here.
Subscribe now to BioOptics World magazine; it's free!